www.allsides.com
Moderna says its combination Covid and flu vaccine works well in late-stage trial
Moderna said on Monday its combination vaccine to protect against both Covid and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against the viruses in a late-stage trial.
In the study, the combination using messenger RNA technology generated greater antibodies than currently marketed traditional flu vaccines and Moderna’s Spikevax mRNA Covid shot, the company said.
The vaccine, called mRNA-1083,...
New Posts (Home)
ChatBox
Popular Posts 
Game Zone
Top PodCasts
